INTRAOKULARLINSENINJEKTOR

European patent · EP3556322 · Deleted

Register entry

Publication number
EP3556322
Application number
EP17884933
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Dec 15, 2017
Published
Oct 23, 2019
Granted
Apr 23, 2025
Deleted
Jul 23, 2026
Reason
Annual fee unpaid
IPC classes
A61F 2/16 (2006.01)
Priority
JP 2016245504 19.12.2016
JP 2016245505 19.12.2016
PCT application
PCT/JP2017/045165 15.12.2017
PCT publication
WO2018/116992 28.06.2018
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 23, 2026

    Deleted, fee unpaid

    Status of protective title
    Active → Cancelled
    Cancellation date
    23.07.2026
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 23.07.2026

  2. Mar 4, 2026

    Change

    Published in Swissreg on 04.03.2026

  3. Apr 23, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 23.04.2025

Parties

Holder

SANTEN PHARMACEUTICAL CO., LTD.

Santen Pharmaceutical Co., Ltd.

9-19, Shimoshinjo 3-chome, Higashiyodogawa-ku Osaka-shi Osaka 533-8651, JP

Inventor

MATSUMOTO, Kazuma

Osaka-shi Osaka 533-8651, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.